10.1002/ejoc.201901350
European Journal of Organic Chemistry
FULL PAPER
oils (minor diastereoisomer 9a: 8 mg, 7% yield; major diastereoisomer
9b: 79 mg, 66% yield). 9a: 1H NMR (CDCl3, 400 MHz): δ (ppm) 8.00-7.93
(m, 2H, HAr), 7.55 (m, 1H, HAr), 7.50-7.43 (m, 2H, HAr), 7.37-7.22 (m, 5H,
HAr), 3.74 (s, 2H, CH2), 2.62-2.43 (m, 4H, CH2, 2 CH), 2.32 (dd, 1H,
J = 13.6, 7.1 Hz, 1H, CH2), 2.25 (dd, 1H, J = 13.9, 6.2 Hz, 1H, CH2), 2.04
(dd, 1H, J = 13.7, 7.1 Hz, 1H, CH2), 1.81 (dd, 1H, J = 13.6, 4.8 Hz, 1H,
CH2), 1.04 (d, J = 6.7 Hz, 3H, CH3). 13C NMR (CDCl3, 100 MHz): δ (ppm)
182.9 (C=O), 159.7 (C=N), 138.6 (CAr), 132.6 (CAr), 129.0 (2 CAr), 128.9
(2 CAr), 128.7 (2 CAr), 128.0 (2 CAr), 127.1 (CAr), 126.2 (CAr), 75.5 (C),
45.3 (CH2), 43.1 (CH), 42.1 (CH2), 37.1 (CH), 36.7 (CH2), 31.9 (CH2),
14.8 (CH3). 9b: 1H NMR (CDCl3, 400 MHz): δ (ppm) 8.01-7.94 (m, 2H,
HAr), 7.62-7.53 (m, 1H, HAr), 7.50-7.43 (m, 2H, HAr), 7.37-7.21 (m, 5H,
HAr), 3.74 (d, J = 0.9 Hz, 2H, CH2), 2.69-2.54 (m, 3H, CH2, 2 CH), 2.50-
2.42 (m, 1H, CH2), 2.19 (dd, 1H, J = 13.7, 6.9 Hz, 1H, CH2), 2.14-2.09 (m,
2H, CH2), 1.91 (dd, 1H, J = 13.7, 5.8 Hz, 1H, CH2), 1.00 (d, J = 6.8 Hz,
3H, CH3). 13C NMR (CDCl3, 100 MHz): δ (ppm) 182.0 (C=O), 159.8
(C=N), 138.5 (CAr), 132.7 (CAr), 129.0 (2 CAr2), 128.9 (2 CAr), 128.6 (2
CAr), 128.0 (2 CAr), 127.1 (CAr), 126.2 (CAr), 74.0 (C), 45.7 (CH2), 43.0
(CH2), 42.5 (CH), 37.8 (CH2), 36.5 (CH), 32.1 (CH2), 15.0 (CH3). IR
(neat): ν = 2924, 1812, 1650, 1452, 1324, 1290 cm-1. HRMS (ESI+): m/z
(M+Na+) calcd for C22H23NNaO2S: 388.1342, found: 388.1343.
added to
a
solution of
9
(90 mg, 0.25 mmol, 30:70 mixture of
diastereoisomers) in DMSO (2 mL) at rt. The reaction mixture was stirred
at 40 °C for 16 h then diluted with EtOAc and brine. The phases were
separated and the aqueous fraction was extracted with EtOAc (2 x 5 mL).
The combined organic layers were dried over anhydrous Na2SO4, filtered
and concentrated in vacuo. Purification by flash chromatography
(Cyclohexane/Et2O 6:4, then 5:5) afforded compound 12 as a 30:70
mixture of two inseparable diastereoisomers (110 mg, 95%, white solid);
mp
= 154-156 °C. From 11: DMPA (2.9 mg, 12 µmol) and
benzylmercaptan (13.5 µL, 115 µmol) were added to a solution of 11 (40
mg, 115 µmol) in degassed DMF (6 mL) at rt. The reaction mixture was
stirred at rt under UV irradiation (365 nm) for 1 h then diluted with EtOAc
and brine. The phases were separated and the aqueous fraction was
extracted with EtOAc (2 x 5 mL). The combined organic layers were dried
over anhydrous Na2SO4, filtered and concentrated in vacuo. Purification
by flash chromatography (Cyclohexane/Et2O 6:4, then 5:5) provided the
spiro compound 12 as a 70:30 mixture of diastereoisomers (50 mg, 92%
yield, white solid). 1H NMR (CDCl3, 400 MHz): δ (ppm) 7.72-7.70 (m, 2H,
HAr), 7.50-7.40 (m, 2H, HAr), 7.39-7.33 (m, 2H, HAr), 7.30-7.15 (m, 11H,
HAr, NH), 7.05 (s, 0.3H, NH), 6.37 (s, 0.7H, NH), 4.36-4.30 (m, 2H, NCH2),
3.68 (d, J = 12.0 Hz, 1H, SCH2), 3.63 (d, J = 12.0 Hz, 1H, SCH2), 2.81
(dd, J = 14.0, 7.1 Hz, 0.3H, CH2), 2.74 (dd, J = 13.7, 6.3 Hz, 0.3H, CH2),
2.50-2.42 (m, 0.7H, CH2), 2.37-2.17 (m, 5.4H, CH2, CH), 2.12-2.06 (m,
0.7H, CH2), 1.86 (dd, J = 13.7, 6.6 Hz, 0.3H, CH2), 1.69 (dd, J = 14.0, 6.1
Hz, 0.3H, CH2), 0.88 (d, J = 6.5 Hz, 0.9H, CH), 0.84 (d, J = 6.0 Hz, 2.1H,
CH3). 13C NMR (CDCl3, 100 MHz): δ (ppm) 174.3 (0.3 C=O), 173.6 (0.7
C=O), 168.1 (0.7 C=O), 167.6 (0.3 C=O), 138.7 (0.3 CAr), 138.7 (0.7 CAr),
138.6 (0.7 CAr), 138.3 (0.3 CAr), 134.2 (0.7 CAr), 133.9 (0.3 CAr), 132.0
(0.3 CAr), 132.0 (0.7 CAr), 128.9 (0.3 CAr), 128.8 (0.7 CAr), 128.7 (0.3 CAr),
128.7 (0.7 CAr), 128.6 (0.3 CAr), 128.6 (0.3 CAr), 128.6 (0.7 CAr), 128.5
(0.7 CAr), 127.4 (0.7 CAr), 127.3 (0.3 CAr), 127.2 (0.7 CAr), 127.2 (0.3 CAr),
127.2 (0.3 CAr), 127.2 (0.7 CAr), 127.1 (0.3 CAr), 127.0 (0.7 CAr), 67.0 (0.7
C), 66.3 (0.3 C), 45.0 (0.3 CH2), 44.5 (0.7 CH2), 43.7 (NCH2), 42.6 (0.3
CH2), 41.3 (0.7 CH2), 41.2 (0.3 CH), 40.6 (0.7 CH), 37.1 (0.7 SCH2), 36.5
(0.3 SCH2), 35.9 (0.3 CH), 34.3 (0.7 CH), 32.7 (0.7 CH2), 32.2 (0.3 CH2),
15.2 (0.7 CH3), 15.1 (0.3 CH3). IR (neat): ν = 3289, 2916, 1654, 1525,
1492, 1313, 1074, 1030 cm-1. HRMS (ESI+): m/z (M+Na+) calcd for
C29H32N2NaO2Si: 495.2077, found: 495.2072.
4,4-Bis(3-(benzylthio)propyl)-2-phenyloxazol-5(4H)-one (10): DMPA
(26 mg, 0.10 mmol) was added to a solution of 5a (241 mg, 1.0 mmol) in
benzylmercaptan (1.2 mL, 10.0 mmol). The reaction mixture was stirred
at rt under UV irradiation (365 nm) for 1 h then diluted with EtOAc and
brine. The phases were separated and the aqueous fraction was
extracted with EtOAc (2 x 5 mL). The combined organic layers were dried
over anhydrous Na2SO4, filtered and concentrated in vacuo. Purification
by flash chromatography (Cyclohexane/Et2O 98:2, then 95:5) afforded
compound 10 (465 mg, 95% yield) as a colorless oil. 1H NMR (CDCl3,
400 MHz): δ (ppm) 8.06-8.00 (m, 2H, HAr), 7.66-7.59 (m, 1H, HAr),
7.58-7.50 (m, 2H, HAr), 7.34-7.26 (m, 8H, HAr), 7.26-7.20 (m, 2H, HAr),
3.68 (s, 4H, SCH2), 2.41 (t, J = 7.1 Hz, 4H, CH2), 2.03-1.89 (m, 4H, CH2),
1.61-1.39 (m, 4H, CH2). 13C NMR (CDCl3, 100 MHz): δ (ppm) 180.1
(C=O), 160.2 (C=N), 138.3 (2 CAr), 132.9 (CAr), 128.9 (2 CAr), 128.8 (4
CAr), 128.5 (4 CAr), 128.0 (2 CAr), 127.0 (2 CAr), 125.7 (CAr), 73.0 (C), 36.3
(2 CH2), 36.1 (2 CH2), 30.9 (2 CH2), 23.5 (2 CH2). IR (neat): ν = 3289,
2916, 1816, 1652, 1495, 1452, 1290, 1073, 1004 cm-1. HRMS (ESI+):
m/z (M+Na+) calcd for C29H31NNaO2S2: 512.1688, found: 512.1687.
N-(4-(Benzylcarbamoyl)-1,7-bis(benzylthio)heptan-4-yl)benzamide
(13): From 10: Benzylamine (9 µL, 82 µmol) was added to a solution of
10 (40 mg, 82 µmol) in DMSO (1 mL) at rt. The reaction mixture was
stirred at 40 °C for 16 h then diluted with EtOAc and brine. The phases
were separated and the aqueous fraction was extracted with EtOAc (2 x
2 mL). The combined organic layers were dried over anhydrous Na2SO4,
filtered and concentrated in vacuo. Purification by flash chromatography
(Cyclohexane/EtOAc 7:3) afforded compound 13 (45 mg, 95% yield) as a
colorless oil. From 11: DMPA (13 mg, 0.10 mmol) was added to a
solution of 11 (174 mg, 0.51 mmol) in benzylmercaptan (0.6 mL,
5.10 mmol). The reaction mixture was stirred at rt under UV irradiation
(365 nm) for 1 h then diluted with EtOAc and brine. The phases were
separated and the aqueous fraction was extracted with EtOAc (2 x 5 mL).
The combined organic layers were dried over anhydrous Na2SO4, filtered
and concentrated in vacuo. Purification by flash chromatography
(Cyclohexane/Et2O 8:2) afforded compound 13 (271 mg, 90% yield) as a
colorless oil. 1H NMR (CDCl3, 400 MHz): δ (ppm) 7.86-7.81 (m, 2H, HAr),
7.78 (s, 1H, NH), 7.55-7.48 (m, 1H, HAr), 7.45-7.41 (m, 2H, HAr), 7.38-
7.16 (m, 15H, HAr), 6.21 (t, J = 5.6 Hz, 1H, NHCH2), 4.49 (d, J = 5.6 Hz,
2H, NHCH2), 3.58 (d, J = 12.0 Hz, 2H, SCH2), 3.54 (d, J = 12.0 Hz, 2H,
SCH2), 2.84-2.71 (m, 2H, CH2), 2.40 (ddd, J = 13.0, 7.1, 5.5 Hz, 2H,
CH2), 2.26 (ddd, J = 13.0, 6.6, 5.4 Hz, 2H, CH2), 1.71-1.54 (m, 4H, CH2),
1.35-1.22 (m, 2H, CH2). 13C NMR (CDCl3, 100 MHz): δ (ppm) 173.1
(C=O), 166.0 (C=O), 138.4 (2 CAr), 137.7 (CAr), 134.9 (CAr), 131.7 (CAr),
129.1 (2 CAr), 128.9 (4 CAr), 128.8 (2 CAr), 128.6 (4 CAr), 128.1 (2 CAr),
N-(4-(Benzylcarbamoyl)hepta-1,6-dien-4-yl)benzamide
(11):
Benzylamine (0.14 mL, 1.24 mmol) was added to a solution of oxazolone
5a (300 mg, 1.24 mmol) in DMSO (6 mL) at rt. The reaction mixture was
stirred at 40 °C for 16 h then diluted with EtOAc and brine. The phases
were separated and the aqueous fraction was extracted with EtOAc (2 x
15 mL). The combined organic layers were dried over anhydrous Na2SO4,
filtered and concentrated in vacuo. Purification by flash chromatography
(Cyclohexane/Et2O 6:4) afforded compound 11 (431 mg, quantitative
yield) as a white solid; mp = 154-156 °C. 1H NMR (CDCl3, 400 MHz): δ
(ppm) 7.75-7.70 (m, 2H, HAr), 7.50-7.45 (m, 1H, HAr), 7.42-7.36 (m, 2H,
HAr), 7.32-7.22 (m, 6H, HAr, NH), 6.92 (t, J = 5.8 Hz, 1H, NH), 5.69 (dddd,
J = 16.1, 11.0, 7.9, 6.7 Hz, 2H, CH=CH2), 5.14-5.04 (m, 4H, CH=CH2),
4.46 (d, J = 5.8 Hz, 2H, CH2N), 3.14 (ddt, J = 14.2, 7.9, 1.1 Hz, 2H, CH2),
2.70 (ddt, J = 14.2, 6.7, 1.3 Hz, 2H, CH2). 13C NMR (CDCl3, 100 MHz): δ
(ppm) 172.5 (C=O), 167.1 (C=O), 138.0 (CAr), 135.0 (CAr), 132.4 (2
CH=CH2), 131.8 (CAr), 128.8 (2 CAr), 128.8 2 (CAr), 127.9 (2 CAr), 127.7
(CAr), 127.0 (2 CAr), 119.9 (2 CH=CH2), 63.4 (C), 44.2 (CH2), 39.9 (CH2).
IR (neat): ν = 3245, 2925, 1745, 1666, 1640, 1599, 1525, 1495, 1313,
1249, 1127 cm-1. HRMS (ESI+): m/z (M+H+) calcd for C22H25N2O2:
349.1911, found: 349.1903.
N-(1-(Benzylcarbamoyl)-3-((benzylthio)methyl)-4-methylcyclo-
pentyl)-benzamide (12): From 9: Benzylamine (27 µL, 0.25 mmol) was
This article is protected by copyright. All rights reserved.